E Zaimis. Show Affiliations »
Abstract
Mesh: See more » Adrenergic beta-Agonists/pharmacologyAdrenergic beta-Agonists/therapeutic useAdultAnimalsButylamines/pharmacologyButylamines/therapeutic useElectric StimulationEthanolamines/pharmacologyEthanolamines/therapeutic useHumansInjections, IntramuscularLegMaleMetaproterenol/administration & dosageMetaproterenol/therapeutic useMuscle Contraction/drug effectsMuscle Cramp/drug therapyMuscle Spasticity/drug therapyMuscle Tonus/drug effectsMuscles/drug effectsPhenethylamines/pharmacologyPhenethylamines/therapeutic useTime Factors
Substances: See more » Adrenergic beta-AgonistsButylaminesEthanolaminesPhenethylaminesMetaproterenol
Year: 1973 PMID: 4119710 DOI: 10.1016/s0140-6736(73)90255-9
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321